Literature DB >> 12846363

A meta-analysis of asthma and risk of lung cancer (United States).

Alfredo A Santillan1, Carlos A Camargo, Graham A Colditz.   

Abstract

OBJECTIVE: To review epidemiologic evidence that asthma is a risk factor for lung cancer, with particular attention to the role of smoking on this association.
METHODS: Through MEDLINE computer searches (January 1966 to April 2002) and a review of references, we identified studies with quantitative data on the relation of asthma to lung cancer. Summary estimates of relative risks (RR) were calculated using the fixed-effects model or the random-effects model as appropriate.
RESULTS: The combined results from five case-control studies--that presented data limited to individuals who had never smoked--showed a 1.8-fold increase in lung cancer risk among asthmatics (95% confidence interval (CI) = 1.3-2.3). The results from six case-control and four cohort studies, which controlled for smoking history also were significant (RR = 1.7; 95% CI = 1.3-2.2). Finally, to illustrate the potential confounding by tobacco, we combined data from seven cohort studies that did not control for smoking history and found an overall RR of 1.4 (95% CI = 1.2-1.6).
CONCLUSIONS: The increased risk of lung cancer among never smoking individuals with asthma supports a direct relation between asthma and lung cancer. There is biological evidence to support this association.

Entities:  

Mesh:

Year:  2003        PMID: 12846363     DOI: 10.1023/a:1023982402137

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  45 in total

1.  Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis.

Authors:  Haris G Vikis; Andrew E Gelman; Andrew Franklin; Lauren Stein; Amy Rymaszewski; Jihong Zhu; Pengyuan Liu; Jay W Tichelaar; Alexander S Krupnick; Ming You
Journal:  Mol Carcinog       Date:  2011-10-17       Impact factor: 4.784

2.  Asthma history, occupational exposure to pesticides and the risk of non-Hodgkin's lymphoma.

Authors:  Won Jin Lee; Mark P Purdue; Patricia Stewart; Maryjean Schenk; Anneclaire J De Roos; James R Cerhan; Richard K Severson; Wendy Cozen; Patricia Hartge; Aaron Blair
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

Review 3.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 4.  The barrier hypothesis and Oncostatin M: Restoration of epithelial barrier function as a novel therapeutic strategy for the treatment of type 2 inflammatory disease.

Authors:  Kathryn L Pothoven; Robert P Schleimer
Journal:  Tissue Barriers       Date:  2017-06-13

5.  Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models.

Authors:  William J McCarthy; Rafael Meza; Jihyoun Jeon; Suresh H Moolgavkar
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

6.  C-reactive protein and risk of lung cancer.

Authors:  Anil K Chaturvedi; Neil E Caporaso; Hormuzd A Katki; Hui-Lee Wong; Nilanjan Chatterjee; Sharon R Pine; Stephen J Chanock; James J Goedert; Eric A Engels
Journal:  J Clin Oncol       Date:  2010-04-26       Impact factor: 44.544

7.  Self-reported prior lung diseases as risk factors for non-small cell lung cancer in Mexican Americans.

Authors:  Michelle K McHugh; Matthew B Schabath; Chung-Han Ho; Mei Liu; Anthony M D'Amelio; Anthony J Greisinger; George L Delclos; Margaret R Spitz; Carol J Etzel
Journal:  J Immigr Minor Health       Date:  2013-10

8.  Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice.

Authors:  Konstantinos Doris; Sophia P Karabela; Chrysoula A Kairi; Davina Cm Simoes; Charis Roussos; Spyros G Zakynthinos; Ioannis Kalomenidis; Timothy S Blackwell; Georgios T Stathopoulos
Journal:  Respir Res       Date:  2010-08-26

9.  Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study.

Authors:  Jill Koshiol; Melissa Rotunno; Dario Consonni; Angela Cecilia Pesatori; Sara De Matteis; Alisa M Goldstein; Anil K Chaturvedi; Sholom Wacholder; Maria Teresa Landi; Jay H Lubin; Neil E Caporaso
Journal:  PLoS One       Date:  2009-10-08       Impact factor: 3.240

10.  Lung inflammation, injury, and proliferative response after repetitive particulate hexavalent chromium exposure.

Authors:  Laura M Beaver; Erik J Stemmy; Arnold M Schwartz; Jesse M Damsker; Stephanie L Constant; Susan M Ceryak; Steven R Patierno
Journal:  Environ Health Perspect       Date:  2009-08-19       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.